Transgenic Operative Products
2006
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$1.1M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of a drug discovery technology designed to help in the detection of toxic compounds in food products. The company's technology specializes in the generation of vectors and cells for research with optic imaging that helps in detecting toxic chemical compounds in the environment and food products, enabling clients to have the visualization of molecular events in real time and in all the organs, with high precision.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Via Einstein
- Località Cascina Codazza
- 26900 Lodi
- Italy
+39 0371 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Transgenic Operative Products’s full profile, request a free trial.
Transgenic Operative Products Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | $1.1M | 00.00 | Completed | Startup |
Transgenic Operative Products Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Finlombarda Gestioni | Venture Capital | Minority | 000 0000 | 000000 0 |
Transgenic Operative Products Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Adriana Maggi | Co-Founder, Board Member & President | ||
| Paolo Ciana Ph.D | Co-Founder, Board Member & Vice President |
Transgenic Operative Products Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alberto Trombetta Ph.D | Finlombarda Gestioni | Board Member | 000 0000 | |
| Carlo Rosa | Self | Board Member | 000 0000 | |
| Dario Casati | Self | Board Member | 000 0000 |